Roscovitine regulates invasive breast cancer cell (MDA-MB231) proliferation and survival through cell cycle regulatory protein cdk5-Reference-Cited by-同舟云学术

Roscovitine regulates invasive breast cancer cell (MDA-MB231) proliferation and survival through cell cycle regulatory protein cdk5

Published:2007-02 Issue:1 Volume:82 Page:25-32
ISSN:0014-4800
Container-title:Experimental and Molecular Pathology
language:en
Short-container-title:Experimental and Molecular Pathology

Author:

Goodyear Shaun,Sharma Mahesh C.

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Molecular Biology,Pathology and Forensic Medicine

Reference37 articles.

1. Cyclin D1 is a nuclear protein required for cell cycle progression in G1;Baldin;Genes Dev.,1993

2. Mice lacking p35, a neuronal specific activator of Cdk5, display cortical lamination defects, seizures, and adult lethality;Chae;Neuron,1997

3. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells;Cowley;Cell,1994

4. Kringle 5 of human plasminogen induces apoptosis of endothelial and tumor cells through surface-expressed glucose-regulated protein 78;Davidson;Cancer Res.,2005

5. Identification of molecular targets associated with selenium-induced growth inhibition in human breast cells using cDNA microarrays;Dong;Cancer Res.,2002

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. p35/CDK5 Regulates Bladder Cancer Proliferation and Migration and Promotes Higher Tumor Grade and Poor Survival Rate in Patients With Bladder Cancer;Anticancer Research;2024-02

2. Olive and Winter Jujube Seeds in Cancer Prevention and Treatment;Seeds: Anti-proliferative Storehouse for Bioactive Secondary Metabolites;2024

3. Elevated CDK5R1 expression associated with poor prognosis, proliferation, and drug resistance in colorectal and breast malignancies: CDK5R1 as an oncogene in cancers;Chemico-Biological Interactions;2022-12

4. Machine Learning-Based Virtual Screening for the Identification of Cdk5 Inhibitors;International Journal of Molecular Sciences;2022-09-13

5. Heterocyclic Anti-cancer Compounds Derived from Natural Sources with their Mechanism of Action;Key Heterocyclic Cores for Smart Anticancer Drug–Design Part I;2022-07-04